Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease.
Level 5 - mechanism / opinion, no new human data
Animal research without human clinical data
PubMed 25488613 · doi:10.1016/j.bcmd.2014.11.004
What was done
Sickle cell (SS) mice were fed a rodent diet supplemented with 3% docosahexanoic acid (DHA) or a total fat-matched control diet for 8 weeks. Red blood cells were evaluated for stiffness using atomic force microscopy, deformability using ektacytometry, and the proportion of irreversibly sickled cells on peripheral blood smears, with comparisons also made to wild-type mice.
What was found
SS mice on the control diet showed increased RBC stiffness and decreased deformability compared to wild-type mice. SS mice receiving the DHA diet showed markedly decreased stiffness and increased deformability compared to SS mice on the control diet, along with a 40% reduction in irreversibly sickled red blood cells. Specific numerical values and variance for stiffness and deformability were not reported in the abstract.
Why it matters
This study demonstrates that dietary DHA improves red blood cell membrane flexibility and reduces sickling in a sickle cell mouse model, supporting further investigation into omega-3 fatty acids as a nutritional strategy in sickle cell disease.
Limits
This is an animal study in mice, and findings cannot be directly applied to human clinical management without clinical trials. The abstract does not report the total sample size (n), baseline values, or specific numerical data and confidence intervals for the stiffness and deformability assays. Clinical in vivo endpoints such as vaso-occlusion rates or organ damage were not evaluated.
Cited by
- supports Omega-3 fatty acids incorporate into cell membranes, making red blood cells more flexible.